Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microtransplantation After Chemotherapy in Intermediate-Risk AML < 60 Years
NCT02587871Phase 2Withdrawn
- Sponsor
- University of Southern California
- Start
- Dec 2018
- Primary completion
- Nov 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of G-CSF mobilized peripheral blood cells in acute myeloid leukemia (AML), sponsored by University of Southern California. Planned start Dec 2018; status: withdrawn.
02
Drugs
G-CSF mobilized peripheral blood cells
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02587871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02587871.